Ondine Biopharma, while helping to launch a photodisinfection system for periodontitis, posted a $1.14 million loss for the first quarter (end-March 31).
With its business partner, Periowave Dental Technologies (PDT), Ondine has launched a cordless photodisinfection laser and a reformulated photosensitizer, sold under the name Periowave.
The company's first quarter loss was an improvement over the same quarter in 2009, when it lost $1.45 million.
It received $120,000 in revenue in this year's first quarter as a supplier to PDT of the Periowave laser base stations and treatment kits. Its direct-to-market product sales were $190,000.
Copyright © 2010 DrBicuspid.com
.hpp4JFpXkV.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
